Atziri Corin Chavez Alvarez
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 28, 2026
Design, Synthesis, and Structure-Activity Relationships of Substituted Phenyl Cyclobutylureas as Potential Modulators of Inflammatory Responses.Atziri Corin Chavez Alvarez, Antoine Carpentier, Ahmed Sahli
|Mar 28, 2026
Coumarin-Based Prodrugs: Therapeutic Promise or Still Confined to Preclinical Exploration?Atziri Corin Chavez Alvarez, Emmanuel Moreau
|Feb 26, 2025
Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models.Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Vincent Ouellette
|Sep 16, 2024
Pyridinyl 4-(2-oxoalkylimidazolidin-1-yl)benzenesulfonates and their hydrochloride salts as novel water soluble antimitotic prodrugs bioactivated by cytochrome P450 1A1 in breast cancer cells.Vincent Ouellette, Chahrazed Bouzriba, Atziri Corin Chavez Alvarez
|Feb 13, 2023
Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes.Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Emmanuel Moreau
Pageof 1
